Search for: "Apotex Inc."
Results 501 - 520
of 674
Sort by Relevance
|
Sort by Date
1 Oct 2009, 2:14 am
Apotex Corp., 2008 WL 2047979 (S.D. [read post]
15 Sep 2009, 10:54 pm
Apotex Corp., 439 F.3d 1312, 1317 (Fed. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi Sankyo Co Ltd… [read post]
5 Jul 2009, 9:13 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
25 Jun 2009, 4:29 am
Apotex Inc., 521 F.3d 253 (3d Cir. 2008). [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
20 Jun 2009, 3:58 pm
Apotex Inc. the Ontario Court of Appeal held that the case was not one where summary judgment was available because the case, at its core, would involve the assessment of conflicting evidence. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
27 May 2009, 12:44 am
Apotex, Inc., 1-09-cv-01518(NJD May 22, 2009, Supplemental Opinion) (Bumb, J.) [read post]
13 May 2009, 11:44 pm
Apotex, Inc., 480 F.3d 1348, 1361 (Fed. [read post]
27 Apr 2009, 9:43 am
Rep. 2, Andrews Pharmaceutical Litigation Reporter April 20, 2009Bristol-Myers Squibb Co. will pay $2.1 million in civil penalties to settle charges that it lied to federal regulators about a silent agreement not to compete with Apotex Inc. once the generics maker unveiled its own version of the popular blood thinner Plavix. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
7 Apr 2009, 4:08 am
Federal Trade Commission about his dealings in 2006 with Canadian generic drugmaker Apotex Inc.Story in NY Times.Wonder when the New York Times will write about the criminal indictments against Pfizer execs and their Bextra related off-label crimes? [read post]
23 Mar 2009, 2:26 pm
More on Apotex, Inc. v. [read post]
23 Mar 2009, 7:34 am
Apotex, Inc. after the jump. [read post]
4 Mar 2009, 12:19 pm
Apotex, Inc., No. 08-437, an implied preemption decision out of the Third Circuit involving an anti-depressant, pending the outcome of Wyeth. [read post]
